Literature DB >> 23041574

Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction.

Song-Yan Liao1, Hung-Fat Tse, Yau-Chi Chan, Pandora Mei-Chu Yip, Yuelin Zhang, Yuan Liu, Ronald A Li.   

Abstract

BACKGROUND: Cellular replacement strategies using embryonic stem cell-derived cardiomyocytes (ESC-CMs) have been shown to improve left ventricular (LV) ejection fraction and prevent LV remodeling post-myocardial infarction (MI). Nonetheless, the immature electrical phenotypes of ESC-CMs may increase the risk of ventricular tachyarrhythmias (VTs) and sudden death.
OBJECTIVE: To investigate whether the forced expression of Kir2.1-encoded inward rectifying K(+) channels that are otherwise absent in ESC-CMs would attenuate their proarrhythmic risk after transplantation post-MI.
METHODS: Mouse ESC line stably transduced with a lentivirus (LentV)-based doxycycline (DOX)-inducible system coexpressing the transgenes Kir2.1 and a dsRed (LentV-THM-Kir2.1-GFP/LentV-TR-KRAB-dsRed) was differentiated into ESC-CMs with (DOX(+)) or without (DOX(-)) treatment with DOX. Detailed in vitro and in vivo assessments of LV function and cardiac electrophysiology were measured 4 weeks after transplantation.
RESULTS: ESC-CM DOX(+) with atrial and ventricular phenotype exhibited more hyperpolarizing resting membrane potential than did ESC-CM DOX(-) (P< .05). Transplantations of ESC-CM DOX(-) and ESC-CM DOX(+) both significantly improved LV ejection fraction, LV end-systolic diameter, end-systolic pressure-volume relationship, and positive maximal and negative pressure derivative (P< .05) at 4 weeks compared with the MI group; however, the DOX(-) group (22 of 40, 55%) had a significantly higher early sudden death rate than the DOX(+) group (13 of 40, 32.5%; P = .036). Telemetry monitoring revealed that the DOX(-) group (6.09%±3.65%) had significantly more episodes of spontaneous VT compared with the DOX(+) group (0.92%±0.81%; P< .05). In vivo programmed electrical stimulation at 2 weeks resulted in a significantly higher incidence of inducible VT in the DOX(-) group (9 of 16, 56.25%) compared with the DOX(+) group (3 of 16, 18.75%; P = .031).
CONCLUSIONS: Forced expression of Kir2.1 in ESC-CMs improves their electrical phenotypes and lowers the risk of inducible and spontaneous VT after post-MI transplantation.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041574     DOI: 10.1016/j.hrthm.2012.10.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  16 in total

1.  Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells.

Authors:  Yau-Chi Chan; Sherwin Ting; Yee-Ki Lee; Kwong-Man Ng; Jiao Zhang; Zi Chen; Chung-Wah Siu; Steve K W Oh; Hung-Fat Tse
Journal:  J Cardiovasc Transl Res       Date:  2013-10-01       Impact factor: 4.132

2.  CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Yuanxue Gao; Shuang Wu; Jiayue Pan; Kai Zhang; Xiaoyi Li; Yangyang Xu; Chentao Jin; Xiao He; Jingjing Shi; Lijuan Ma; Fujian Wu; Yao Yao; Ping Wang; Qinggang He; Feng Lan; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-20       Impact factor: 9.236

Review 3.  Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives.

Authors:  Maggie Chow; Kenneth R Boheler; Ronald A Li
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832

4.  Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.

Authors:  Joseph K Yu; Jialiu A Liang; William H Franceschi; Qinwen Huang; Farhad Pashakhanloo; Eric Sung; Patrick M Boyle; Natalia A Trayanova
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 13.081

5.  Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2.

Authors:  Xinran Li; Hesheng Hu; Ye Wang; Mei Xue; Xiaolu Li; Wenjuan Cheng; Yongli Xuan; Jie Yin; Na Yang; Suhua Yan
Journal:  Cardiovasc Drugs Ther       Date:  2015-06       Impact factor: 3.727

Review 6.  CaMKII regulation of cardiac K channels.

Authors:  Julian Mustroph; Lars S Maier; Stefan Wagner
Journal:  Front Pharmacol       Date:  2014-02-21       Impact factor: 5.810

7.  Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy.

Authors:  Yuelin Zhang; Xiaoting Liang; Songyan Liao; Weixin Wang; Junwen Wang; Xiang Li; Yue Ding; Yingmin Liang; Fei Gao; Mo Yang; Qingling Fu; Aimin Xu; Yuet-Hung Chai; Jia He; Hung-Fat Tse; Qizhou Lian
Journal:  Sci Rep       Date:  2015-06-09       Impact factor: 4.379

Review 8.  Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?

Authors:  Song-Yan Liao; Hung-Fat Tse
Journal:  Stem Cell Res Ther       Date:  2013-12-24       Impact factor: 6.832

9.  Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli.

Authors:  Xiaofei Chen; Yan Cao; Hai Zhang; Zhenyu Zhu; Min Liu; Haibin Liu; Xuan Ding; Zhanying Hong; Wuhong Li; Diya Lv; Lirong Wang; Xianyi Zhuo; Junping Zhang; Xiang-Qun Xie; Yifeng Chai
Journal:  Anal Chem       Date:  2014-04-30       Impact factor: 6.986

10.  A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.

Authors:  Xinyang Hu; Yinchuan Xu; Zhiwei Zhong; Yan Wu; Jing Zhao; Yingchao Wang; Haifeng Cheng; Minjian Kong; Fengjiang Zhang; Qi Chen; Jianzhong Sun; Qian Li; Jing Jin; Qingju Li; Lihong Chen; Chen Wang; Hongwei Zhan; Youqi Fan; Qian Yang; Lei Yu; Rongrong Wu; Jie Liang; Jinyun Zhu; Ya Wang; Yiping Jin; Yifan Lin; Fan Yang; Liangliang Jia; Wei Zhu; Jinghai Chen; Hong Yu; Jianyi Zhang; Jian'an Wang
Journal:  Circ Res       Date:  2016-01-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.